Other Species / Isoforms
  DYRK1B (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S49-p
SAPLRKLsVDLIKTY
1 2
DYRK1B (human) SAPLRKLsVDLIKTY S49-p
DYRK1B iso2 (human) SAPLRKLSVDLIKTY S49
DYRK1B (mouse) SAPLRKLSVDLIKTY S49
DYRK1B (rat) SAPLRKLSVDLIKTY S49
K57-ac
VDLIKTYkHINEVyY
0 3
DYRK1B (human) VDLIKTYkHINEVyY K57-ac
DYRK1B iso2 (human) VDLIKTYKHINEVYY K57
DYRK1B (mouse) VDLIKTYKHINEVyY K57
DYRK1B (rat) VDLIKTYkHINEVYY K57-ac
Y63-p
YkHINEVyYAKKKRR
Upstream
0 25
Treatment
  • U0126
DYRK1B (human) YkHINEVyYAKKKRR Y63-p
DYRK1B iso2 (human) YKHINEVYYAKKKRR Y63
DYRK1B (mouse) YKHINEVyYAKKKRR Y63-p
DYRK1B (rat) YkHINEVYYAKKKRR Y63
K127-ub
GSFGQVVkAYDHQTQ
0 1
DYRK1B (human) GSFGQVVkAYDHQTQ K127-ub
DYRK1B iso2 (human) GSFGQVVKAYDHQTQ K127
DYRK1B (mouse) GSFGQVVKAYDHQTQ K127
DYRK1B (rat) GSFGQVVKAYDHQTQ K127
Y271-p
CQLGQRIyQyIQsRF
Upstream
Downstream
3 185
Effects on Modified Protein
  • enzymatic activity, induced
Kinase, in vitro:
  • DYRK1B (human)
Putative in vivo kinases:
  • DYRK1B (human)
Regulatory protein:
  • MKK3 (human)
  • RAC1 (human)
DYRK1B (human) CQLGQRIyQyIQsRF Y271-p
DYRK1B iso2 (human) CQLGQRIYQYIQSRF Y271
DYRK1B (mouse) CQLGQRIyQyIQsRF Y271-p
DYRK1B (rat) CQLGQRIYQyIQsRF Y271
Y273-p
LGQRIyQyIQsRFYR
Upstream
Downstream
4 3632
Effects on Modified Protein
  • enzymatic activity, induced
Kinase, in vitro:
  • DYRK1B (human)
Putative in vivo kinases:
  • DYRK1B (human)
Regulatory protein:
  • MKK3 (human)
  • RAC1 (human)
Treatment
  • angiotensin-(1-7)
  • anti-CD28
  • anti-CD3
  • HGF
  • LRRK2-IN-1
  • metastatic potential
DYRK1B (human) LGQRIyQyIQsRFYR Y273-p
DYRK1B iso2 (human) LGQRIYQYIQSRFYR Y273
DYRK1B (mouse) LGQRIyQyIQsRFYR Y273-p
DYRK1B (rat) LGQRIYQyIQsRFYR Y273-p
S276-p
RIyQyIQsRFYRSPE
0 394
DYRK1B (human) RIyQyIQsRFYRSPE S276-p
DYRK1B iso2 (human) RIYQYIQSRFYRSPE S276
DYRK1B (mouse) RIyQyIQsRFYRSPE S276-p
DYRK1B (rat) RIYQyIQsRFYRSPE S276-p
S421-p
YEPAARIsPLGALQH
Upstream
Downstream
1 3
Effects on Modified Protein
  • enzymatic activity, induced
Kinase, in vitro:
  • ERK2 (human)
Putative in vivo kinases:
  • DYRK1B (human)
Regulatory protein:
  • KRas (human)
Treatment
  • 4-HT
  • AZ191
  • ischemia
DYRK1B (human) YEPAARIsPLGALQH S421-p
DYRK1B iso2 (human) YEPAARISPLGALQH S381
DYRK1B (mouse) YEPAARIsPLGALQH S421-p
DYRK1B (rat) YEPAARISPLGALQH S381
Y485-p
SDNRTYRysNRYCGG
0 1
DYRK1B (human) SDNRTYRysNRYCGG Y485-p
DYRK1B iso2 (human) SDNRTYRYSNRYCGG Y445
DYRK1B (mouse) NDNRAYRYSNRYCGG Y485
DYRK1B (rat) SDNRAYRYSNRYCGG Y445
S486-p
DNRTYRysNRYCGGP
0 1
DYRK1B (human) DNRTYRysNRYCGGP S486-p
DYRK1B iso2 (human) DNRTYRYSNRYCGGP S446
DYRK1B (mouse) DNRAYRYSNRYCGGP S486
DYRK1B (rat) DNRAYRYSNRYCGGP S446
S576-p
VGGPADCsPPHPAPA
0 1
DYRK1B (human) VGGPADCsPPHPAPA S576-p
DYRK1B iso2 (human) VGGPADCSPPHPAPA S536
DYRK1B (mouse) VGSPPDCSPPPPAPA S576
DYRK1B (rat) VGSPPDCSPPHPAPA S536